Joffrey van Prehn, Elena Reigadas, Erik H Vogelzang, Emilio Bouza, Adriana Hristea, Benoit Guery, Marcela Krutova, Torbjorn Norén, Franz Allerberger, John E Coia, Abraham Goorhuis, Tessel M van Rossen, Rogier E Ooijevaar, Karen Burns, Bente R Scharvik Olesen, Sarah Tschudin-Sutter, Mark H Wilcox, Maria J G T Vehreschild, Fidelma Fitzpatrick, Ed J Kuijper
SCOPE: In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first treatment guidance document for Clostridioides difficile infection (CDI). This document was updated in 2014. The growing literature on CDI antimicrobial treatment and novel treatment approaches, such as faecal microbiota transplantation (FMT) and toxin-binding monoclonal antibodies, prompted the ESCMID study group on C. difficile (ESGCD) to update the 2014 treatment guidance document for CDI in adults...
December 2021: Clinical Microbiology and Infection